Drug
M9140
M9140: highest development phase Phase 1/2, developed by Merck KGaA. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Merck KGaA
Trials
| Drug | Phase | Indication |
|---|---|---|
| M9140 NCT06710132 | Phase 1/2 | Solid Tumors |
Latest
No recent events.
Follow M9140 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.